Weekly Topotecan With Docetaxel in Recurrent Small Cell Lung Cancer

NCT00315211 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped Slow Accrual

Conditions

Mediastinal Neoplasms

Interventions

DRUG: Intravenous Topotecan
DRUG: Intravenous Docetaxel

Sponsor

Aultman Health Foundation

Collaborators

[object Object]